Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Horizon Therapeutics (HZNP) Surpasses Q2 Earnings and Revenue Estimates
10:40am, Tuesday, 08'th Aug 2023
Horizon Therapeutics (HZNP) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.07 per share a year ago.
Horizon's (HZNP) Daxdilimab Fails to Meet Goal in Lupus Study
12:20pm, Monday, 24'th Jul 2023
Horizon (HZNP) fails to meet the primary endpoint in the mid-stage study of evaluating daxdilimab in the treatment of systemic lupus erythematosus.
Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts say
03:59pm, Wednesday, 12'th Jul 2023
The brisk pace of biopharmaceutical deal making seen in the first half of this year may only accelerate in the months ahead, even as regulators take a hard look at some of the bigger deals, analysts s
Why Is Horizon Therapeutics (HZNP) Down 9% Since Last Earnings Report?
12:40pm, Friday, 02'nd Jun 2023
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock?
Amgen: Appeal Becomes Visible Despite Uncertainty On The 'Horizon'
05:36am, Monday, 29'th May 2023
Amgen's stock has seen a further pullback since it announced an acquisition of Horizon Therapeutics in December. Shares are down by nearly a quarter as the re-rating starts to look interesting with fu
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
05:15am, Wednesday, 24'th May 2023
There isn't much overlap between Amgen's business and Horizons', but that isn't stopping the FTC from looking to block the deal. Pfizer has a strong oncology portfolio and is planning to acquire Seage
US judge hearing fight over Amgen deal for Horizon eyes September trial
11:51am, Tuesday, 23'rd May 2023
The judge who will decide if Amgen can go forward with its $27.8 billion purchase of Horizon Therapeutics on Tuesday said he was considering an evidentiary hearing on the matter in September.
Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared Holz
06:24pm, Thursday, 18'th May 2023
Jared Holz, Mizuho healthcare sector strategist, joins 'Fast Money' to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
10:30am, Thursday, 18'th May 2023
The new timeline is earlier than what Amgen, Horizon Therapeutics and Wall Street analysts were initially expecting after the FTC sued to block the deal.
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?
05:13am, Wednesday, 17'th May 2023
The FTC wants to block Amgen's acquisition of Horizon even though the two companies' products don't overlap. The agency thinks that Amgen could try to bundle Horizon's products in a way that discourag
Is This Dow Jones Stock a Buy for Income Investors?
05:06am, Wednesday, 17'th May 2023
Amgen's revenue and profits dipped in the first quarter. The company's market-beating dividend is poised to rise moving forward.
Top 5 Buys of Paul Tudor Jones' Firm in the 1st Quarter
05:19pm, Tuesday, 16'th May 2023
Paul Tudor Jones (Trades, Portfolio), founder and chief investment officer of Boston-based Tudor Investment Group, disclosed in a regulatory filing that his firm's top buys during the first quarter in
FTC sues to block Amgen's $27.8 billion deal to acquire Horizon Therapeutics
04:09pm, Tuesday, 16'th May 2023
Yahoo Finance healthcare reporter Anjalee Khemlani joins the Live Show to discuss details surrounding the FTC suing biopharmaceutical giant Amgen Inc and its plan to block Amgen's $27.8 billion deal t
Jefferies' Michael Yee expects Amgen's Horizon Therapeutics deal will go through despite FTC block
02:51pm, Tuesday, 16'th May 2023
Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss the FTC's move to block Amgen's $27.8 billion deal for Horizon Therapeutics.
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday
12:36pm, Tuesday, 16'th May 2023
The Dow and S&P 500 moved lower Tuesday morning. Sea Limited shares fell as the company's video game segment failed to meet expectations.
